Last $45.26 USD
Change Today +1.85 / 4.26%
Volume 10.1M
ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
Frankfurt
As of 8:04 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ABBOTT LABORATORIES (ABT) in the last 6 months

Announced 12/24/14
UNeLAB LLC
Merger/Acquisition

Abbott Laboratories (NYSE:ABT) acquired UNeLAB from Prairie Ventures, LLC and other shareholders effective December 24, 2014.


ABT's price was unchanged after the transaction was announced on 12/24/14.
Investor / Buyer
Abbott Laboratories
Creditor / Lender
Prairie Ventures, LLC
 
Announced 12/20/14
Abbott Laboratories, 5301 Patrick Henry Drive in Santa Clara
Merger/Acquisition

Insight Realty Co., Pearlmark Real Estate Partners and Kinship Capital acquired 5301 Patrick Henry Drive in Santa Clara from Abbott Laboratories (NYSE:ABT) on December 19, 2014.


ABT's price was unchanged after the transaction was announced on 12/20/14.
Investor / Buyer
Insight Realty Company
Kinship Capital
Pearlmark Real Estate Partners
Creditor / Lender
Abbott Laboratories
 
Announced 10/29/14
250.00M for Topera, Inc.
Merger/Acquisition

Abbott Laboratories (NYSE:ABT) signed an agreement to acquire Topera, Inc. from Alafi Capital Company LLC, New Enterprise Associates and others for approximately $250 million in cash on October 29, 2014. Under the terms of the agreement Abbott will pay $250 million upfront, plus potential future payments tied to performance milestones. The deal is subject to customary closing conditions, including antitrust clearance. It is expected to close in the fourth quarter of ...
Read More


ABT's price was unchanged after the transaction was announced on 10/29/14.
Investor / Buyer
Abbott Laboratories
Creditor / Lender
Alafi Capital Company LLC
New Enterprise Associates
Financial Advisor
Merrill Lynch & Co., Inc.
 
Announced 09/11/14
3.00B for Abbott Laboratories
Buyback

Abbott Laboratories (NYSE:ABT) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its shares. The repurchases may be made from time to time as market conditions warrant and subject to regulatory considerations. The company aims to return value to shareholders. The Board of Directors of Abbott Laboratories has authorized a buyback plan on September 11, 2014. On September 11, 2014, the company initiated ...
Read More


ABT's price was unchanged after the transaction was announced on 09/11/14.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $45.26 USD +1.85

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,732 GBp -29.50
Danaher Corp $83.93 USD +1.08
Eli Lilly & Co $72.11 USD +1.14
Medtronic PLC $73.01 USD -0.40
Teva Pharmaceutical Industries Ltd $57.56 USD -0.37
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 34.1x
Price/Sales 3.0x
Price/Book 2.9x
Price/Cash Flow 24.1x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.